MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 219 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $327,000 | +46.0% | 9,837 | -13.5% | 0.02% | +80.0% |
Q4 2019 | $224,000 | +46.4% | 11,375 | -3.6% | 0.01% | +25.0% |
Q3 2019 | $153,000 | +19.5% | 11,804 | +2.1% | 0.01% | 0.0% |
Q4 2018 | $128,000 | -67.8% | 11,564 | -23.4% | 0.01% | -46.7% |
Q3 2018 | $397,000 | +12.8% | 15,091 | -12.3% | 0.02% | +7.1% |
Q2 2018 | $352,000 | +25.3% | 17,212 | +11.2% | 0.01% | +27.3% |
Q1 2018 | $281,000 | +73.5% | 15,483 | +33.1% | 0.01% | +83.3% |
Q4 2017 | $162,000 | -27.4% | 11,630 | -11.7% | 0.01% | -40.0% |
Q2 2017 | $223,000 | +43.9% | 13,172 | +13.1% | 0.01% | +42.9% |
Q1 2017 | $155,000 | -16.7% | 11,642 | -6.0% | 0.01% | -22.2% |
Q4 2016 | $186,000 | +53.7% | 12,388 | +19.5% | 0.01% | +50.0% |
Q3 2016 | $121,000 | -30.1% | 10,368 | -11.2% | 0.01% | -25.0% |
Q4 2015 | $173,000 | -33.7% | 11,678 | +2.0% | 0.01% | -27.3% |
Q2 2015 | $261,000 | +45.8% | 11,452 | -2.8% | 0.01% | +57.1% |
Q1 2015 | $179,000 | +36.6% | 11,785 | +9.0% | 0.01% | +16.7% |
Q2 2014 | $131,000 | -4.4% | 10,811 | -7.8% | 0.01% | 0.0% |
Q1 2014 | $137,000 | -64.5% | 11,721 | -46.4% | 0.01% | -64.7% |
Q4 2013 | $386,000 | +125.7% | 21,849 | +83.5% | 0.02% | +88.9% |
Q3 2013 | $171,000 | – | 11,910 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |